课题基金 / 基金详情

BARRIERS TO LATINO PARTICIPATION IN CLINICAL TRIALS

BARRIERS TO LATINO PARTICIPATION IN CLINICAL TRIALS
拉丁裔参与临床试验的障碍
批准号:
2842705
负责人:
ANNA C PAVLICK
金额:
$7.32万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2000-09-29

项目摘要

项目成果

ANNA C PAVLICK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed two year special project will continue a program initiated by the Eastern Oncology Cooperative Oncology Group to increase minority participation and enrollment into cancer clinical trials. The continuation of this accrual project will be conducted at Indiana University, an ECOG member institution. Specifically, this project will investigate barriers to the enrollment of Latino Americans into cancer prevention trials focusing upon the role of the community primary care physician. A major activity of the project will involve focus groups with Latino physicians and ECOG physicians who are located in areas with significant Latino populations. Major objectives of the focus group/workshops are: (1) To identify and rank barriers to participation of Latino patients in cancer prevention trials; (2) To develop and test site- specific and community based solutions to barriers identified from physician focus groups; (3) To evaluate and measure impact of focus groups by participation of Latinos in clinical trials selected by physician focus groups; and (4) To export successful solutions to common barriers to other Hispanic Americans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSABP P-2: STUDY OF TAMOXIFEN AND RALOXIFENE( STAR) TO PREVENT BREAST CANCER
Thalidomide and Dacarbazine for Metastatic Melanoma
NSABP P-2: Study of Tamoxifen and Raloxifene( STAR) to Prevent Breast Cancer